Acorda Therapeutics (ACOR)

Acorda (<a href=http://www.zacks.com/stock/quote/acor>ACOR</a>) received some very good news on May 6, 2009 when the U.S. FDA informed the company that the new drug application (NDA) for Fampridine-SR was accepted. The news comes only two weeks after the re-filing of the NDA on April 23, 2009. <p> However, the biggest surprise with the acceptance off the NDA was that the FDA also granted Acorda a priority review for the application. We note this was an independent decision by the FDA, as Acorda did not specifically ask for a priority review. <p> Clearly this is another very good sign and proves that the FDA views MS walking disability as a significant unmet medical need, with Fampridine-SR as potentially a breakthrough product for its treatment. The PDUFA action date has been set for October 22, 2009.

Comments

• Enhanced Categores

  • Analyst Opinions (1431)
  • ETF Picks (87)
  • Mergers and Acquisitions (1705)
  • Stock Picks (1257)
  • Stocks to Sell (405)
  • Uncategorized (62)

• Archives

  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008

• Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

• Pages

  • About Us
  • Contact Us

• 
  

• About

  StockPickBloggers.com brings you the hottest stock picks from the investment community.

• Blogroll

  • Bear of the Day - Zacks is the leading investment research firm focusing on equities earnings estimates and stock analysis for the individual investor, including stock picks, stock screening, portfolio stock tracker and stock screeners.
  • Bull of the Day - Zacks is the leading investment research firm focusing on equities earnings estimates and stock analysis for the individual investor, including stock picks, stock screening, portfolio stock tracker and stock screeners.
  • Hot Stock Picks - Hot stock picks from the stock market neural network scan of Stocknod.com. Get today’s best stock picks from the leader in stock picks analysis.
  • Investools
  • MarketRiders Blog - Asset Allocation, Retirement Investing, ETFs, Vanguard Index Funds, Investment Software
  • Marketwire – Mergers and Acquisitions - Marketwire – Mergers and Acquisitions
  • Motley Fool
  • Seeking Alpha
  • The Stock Advisors - Explore the world of financial newsletters.  For years, independent newsletter advisors have provided their subscribers with better returns than most other sources.  Most of the greatest stock pickers in the world allow us to reprint stock recom
  • The StockCharts.com Market Message - Get exclusive commentary on what’s going on in the market at Stockcharts.com. The Market Message is a paid service, for information regarding signing up please visit http://stockcharts.com.
  • US Economy & Stock Market Analysis with Stock Picks & Free Investing Tips - Stay Connected – Never miss trade
  • Zack's Analyst Opinions - Zacks is the leading investment research firm focusing on equities earnings estimates and stock analysis for the individual investor, including stock picks, stock screening, portfolio stock tracker and stock screeners.